Rua Gold Inc. announced a Preliminary Economic Assessment (PEA) for its 100% owned Auld Creek Gold-Antimony Project in New Zealand, revealing an after-tax NPV of $42 million and an IRR of 17% at $3,300/oz gold price. The project features a high-grade, shallow underground mine with a 5.5-year life, producing about 27,000 ounces of gold equivalent annually. With initial capital costs of $133 million and cash costs of $1,400/oz gold, the study highlights robust cash flow and scalability potential. Rua Gold is advancing drilling and permitting, aiming to complete a Prefeasibility Study by Q4 2026 and secure full permits by mid-2027 to move towards production.
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
The global warehouse shuttle software market is projected to grow from $1.57 billion in 2026 to $2.66 billion by 2030, with a CAGR of 14.1%. Growth is fueled by rising e-commerce, warehouse automation, AI-driven orchestration, and robotic material ha...
The global nucleating and clarifying agents market, valued at $426.33 million in 2025, is projected to grow at a CAGR of 6.8% to reach $868.84 million by 2035. Growth is fueled by rising demand for high-clarity polypropylene packaging, especially in ...
